Notícies http://www.imim.cat/noticies Programa de recerca: Processos inflamatoris i cardiovasculars Efficacy of a drug demonstrated in preclinical models to halt rhabdomyosarcoma growth http://www.imim.cat/noticies/view.php?ID=782 <p>The research team led by the Institut de Recerca Joan de Déu (IRSJD) and the Hospital del Mar Research Institute has, for the first time, demonstrated the efficacy of a drug in animal models developed from samples of patients from the Sant Joan de Déu Hospital. The study identifies the PRKG1 gene as a key element in the biology of rhabdomyosarcoma and as a potential biomarker to predict treatment response. The determination of Cristina&#39;s parents-a girl who passed away from rhabdomyosarcoma in 2015-has been crucial in making this study possible. Their commitment enabled the raising of more than &euro;600,000 to promote research into new treatments for this type of pediatric tumor.</p> 11/12/2025